Lb Pharmaceuticals Inc (LBRX)

05:20 AM

Clear Street initiates LB Pharmaceuticals stock with buy rating By Investing.com - Investing.com Canada

05:20 AM

12:30 PM

LB Pharmaceuticals: Buy Rating Reiterated, $45 Price Target Maintained on LB-102 Late-Stage Pipeline and Multi-Billion-Dollar Sales Potential - TipRanks

12:30 PM

12:00 PM

All You Need to Know About LB Pharmaceuticals Inc (LBRX) Rating Upgrade to Buy - Yahoo Finance

12:00 PM

08:05 AM

H.C. Wainwright reiterates Buy on LB Pharmaceuticals stock, $45 target By Investing.com - Investing.com Nigeria

08:05 AM

08:00 AM

H.C. Wainwright reiterates Buy on LB Pharmaceuticals stock, $45 target - Investing.com

08:00 AM

May 22, 2026

LB Pharmaceuticals Inc (LBRX) Holds Steady Near Resistance as Market Watches for BreakoutCovered Call Trade - Newser

May 22, 2026

May 22, 2026

LB Pharmaceuticals Inc (LBRX) Breaks Higher as Volume Picks Up; Key Resistance AheadRetail Trader Picks - Newser

May 22, 2026

May 19, 2026

Why Is LB Pharmaceuticals Inc Common Stock (LBRX) Stock Down Today? - Meyka

May 19, 2026

May 17, 2026

LB Pharmaceuticals (NASDAQ:LBRX) Is In A Good Position To Deliver On Growth Plans - Sahm

May 17, 2026

May 16, 2026

Number of shareholders of LB Pharmaceuticals Inc – NASDAQ:LBRX - TradingView

May 16, 2026

May 15, 2026

TCG Crossover entities report 1.84M shares in LB Pharmaceuticals (LBRX) - Stock Titan

May 15, 2026

May 15, 2026

Commodore Capital (LBRX) files Schedule 13G/A reporting 1.97M shares - Stock Titan

May 15, 2026

May 15, 2026

Caligan Partners discloses 1.44M shares in LB Pharmaceuticals (LBRX) - Stock Titan

May 15, 2026

May 14, 2026

Craig-Hallum Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX) - The Globe and Mail

May 14, 2026

May 14, 2026

LB Pharmaceuticals (LBRX) Declines -1.02% Amid Market Weakness 2026-05-14Inverse ETF Flow - Newser

May 14, 2026

May 13, 2026

JPMorgan (NYSE: JPM) files amendment showing 1.43M LBRX shares (4.9%) - Stock Titan

May 13, 2026

May 13, 2026

This LB Pharmaceuticals analyst begins coverage on a bullish note; here are top 5 initiations for Monday - MSN

May 13, 2026

May 12, 2026

LBRX: LB-102 demonstrates rapid efficacy and strong safety in late-stage trials for major neuropsychiatric disorders - TradingView

May 12, 2026

May 12, 2026

LB Pharmaceuticals (LBRX) reports $365.6M cash, Q1 net loss $19.1M - Stock Titan

May 12, 2026

May 12, 2026

LB Pharmaceuticals (NASDAQ: LBRX) boosts cash for late-stage LB-102 trials - Stock Titan

May 12, 2026

May 12, 2026

LB Pharmaceuticals (NASDAQ: LBRX) ramps LB-102 trials with $365.6M cash runway to 2029 - Stock Titan

May 12, 2026

May 12, 2026

New schizophrenia and bipolar trials backed by $365.6M at LB Pharmaceuticals - Stock Titan

May 12, 2026

May 12, 2026

LB Pharmaceuticals Q1 net loss widens on higher R&D costs - TradingView

May 12, 2026

May 12, 2026

LB Pharmaceuticals Inc.: Q1 Earnings Snapshot - Barchart.com

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Why LB Pharmaceuticals (LBRX) is still under the radar (+3.85%) 2026-05-11Popular Trader Picks - Newser

May 12, 2026

May 10, 2026

How will LB Pharmaceuticals (LBRX) earnings compare to expectations | Q4 2025: Profit Exceeds ViewsTrading Community - Newser

May 10, 2026

May 06, 2026

Is LB Pharmaceuticals (LBRX) the most overlooked stock right now? (Modest Decline) 2026-05-06Reward Analysis - newser.com

May 06, 2026

May 03, 2026

Jennison Associates LLC Acquires 82,812 Shares of LB Pharmaceuticals Inc $LBRX - MarketBeat

May 03, 2026

May 01, 2026

LBRX LB Pharmaceuticals posts slightly smaller Q4 2025 loss than analyst estimates, shares rise 3.66 percent.High Attention Stocks - newser.com

May 01, 2026

May 01, 2026

LBRX Forecast — Price Target — Prediction for 2027 - TradingView

May 01, 2026

Apr 29, 2026

LBRX News Today | Why did LB Pharmaceuticals stock go down today? - MarketBeat

Apr 29, 2026

Apr 29, 2026

Equities Analysts Offer Predictions for LBRX Q1 Earnings - MarketBeat

Apr 29, 2026

Apr 28, 2026

LB Pharmaceuticals (NASDAQ:LBRX) Raised to "Strong-Buy" at HC Wainwright - MarketBeat

Apr 28, 2026

Apr 28, 2026

LB Pharmaceuticals (NASDAQ:LBRX) Hits New 52-Week HighWhat's Next? - MarketBeat

Apr 28, 2026

Apr 27, 2026

LB Pharmaceuticals (NASDAQ:LBRX) Trading 5.6% HigherTime to Buy? - MarketBeat

Apr 27, 2026

Apr 27, 2026

This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Apr 27, 2026

Apr 27, 2026

LB Pharmaceuticals Inc (NASDAQ:LBRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 27, 2026

Apr 27, 2026

Biopharma breaks its lengthy IPO drought - MSN

Apr 27, 2026

Apr 24, 2026

Analysts Offer Insights on Healthcare Companies: LB Pharmaceuticals, Inc. (LBRX) and West Pharmaceutical Services (WST) - The Globe and Mail

Apr 24, 2026

Apr 23, 2026

[ARS] LB PHARMACEUTICALS INC SEC Filing - Stock Titan

Apr 23, 2026